On September 6th, Stockholm Science City together with Business Sweden will arrange a breakfast seminar on market access and FDA approval in the U.S. The U.S. represents the single largest market opportunity for life science, medtech and digital health companies, and its also known for its fierce competition. Having the right strategy and roadmap is key for success in the U.S., especially in reducing risk.
